ADC Therapeutics SA, of Lausanne, Switzerland, appointed Ron Squarer chair of its board and a company adviser.
Emulate Inc., of Boston, appointed Jim Corbett CEO and Martin Madaus executive chair of its board.
Hemostemix Inc., of Calgary, Alberta, appointed Peter Lacey chair of its board.
JSC Olainfarm, of Olaine, Latvia, appointed Marina Serpova to its management board.
Marinus Pharmaceuticals Inc., of Radnor, Pa., appointed Sasha Damouni Ellis vice president, investor relations and corporate communications.
Rubryc Therapeutics Inc., of San Carlos, Calif., appointed Ramesh Baliga chief science officer.
Tracon Pharmaceuticals Inc., of San Diego, appointed Saundra Pelletier to its board.